Martingale Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $785K | Buy |
13,129
+298
| +2% | +$17.8K | 0.02% | 519 |
|
|
2025
Q1 | $673K | Buy |
12,831
+300
| +2% | +$15.7K | 0.02% | 546 |
|
|
2024
Q4 | $689K | Buy |
12,531
+2
| +0% | +$110 | 0.02% | 549 |
|
|
2024
Q3 | $630K | Buy |
12,529
+1,671
| +15% | +$84K | 0.01% | 579 |
|
|
2024
Q2 | $477K | Buy |
10,858
+100
| +0.9% | +$4.39K | 0.01% | 608 |
|
|
2024
Q1 | $473K | Buy |
10,758
+87
| +0.8% | +$3.83K | 0.01% | 629 |
|
|
2023
Q4 | $507K | Buy |
10,671
+30
| +0.3% | +$1.42K | 0.01% | 611 |
|
|
2023
Q3 | $472K | Buy |
10,641
+100
| +0.9% | +$4.44K | 0.01% | 620 |
|
|
2023
Q2 | $503K | Buy |
10,541
+2,101
| +25% | +$100K | 0.01% | 611 |
|
|
2023
Q1 | $332K | Buy |
8,440
+501
| +6% | +$19.7K | 0.01% | 693 |
|
|
2022
Q4 | $225K | Buy |
7,939
+5
| +0.1% | +$141 | ﹤0.01% | 772 |
|
|
2022
Q3 | $239K | Buy |
7,934
+5
| +0.1% | +$151 | ﹤0.01% | 750 |
|
|
2022
Q2 | $270K | Buy |
7,929
+219
| +3% | +$7.46K | ﹤0.01% | 756 |
|
|
2022
Q1 | $346K | Buy |
7,710
+400
| +5% | +$18K | 0.01% | 706 |
|
|
2021
Q4 | $338K | Buy |
+7,310
| New | +$338K | ﹤0.01% | 720 |
|
|
2020
Q4 | – | Sell |
-17,203
| Closed | -$368K | – | 970 |
|
|
2020
Q3 | $368K | Buy |
+17,203
| New | +$368K | ﹤0.01% | 870 |
|